legislationactive5 updates

HB 2057: Prohibits insurers offering policies or certificates of health insurance and pharmacy benefit managers from requiring that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug.

Tracking HB 2057 through the Oregon Legislature.

Updates

Newest first · click to expand
Bill ActionJune 27, 2025HB 2057

House: In committee upon adjournment.

Bill ActionApril 1, 2025HB 2057

House: Work Session held.

TestimonyMarch 11, 2025HB 2057

House: Public Hearing held.

Bill ActionJanuary 17, 2025HB 2057

House: Referred to Behavioral Health and Health Care.

Bill ActionJanuary 13, 2025HB 2057

House: First reading. Referred to Speaker's desk.